CorMedix (CRMD) Shares Outstanding (Weighted Average) (2010 - 2025)

CorMedix has disclosed Shares Outstanding (Weighted Average) across 16 years of filings, most recently posting $72034.0 for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $72034.0, up 22.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $72034.0 (up 22.36% YoY), and the FY2025 annual result was $72034.0, up 22.36% from the prior year.
• Shares Outstanding (Weighted Average) came in at $72034.0 for Q4 2025 at CorMedix, down from $69.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $69.7 million in Q3 2025 to a low of $7.72 in Q3 2021.
• The 5-year median for Shares Outstanding (Weighted Average) is $42.2 million (2022), against an average of $38.2 million.
• Across the five-year window, Shares Outstanding (Weighted Average) slumped 100.0% in 2021 and jumped 514786881.87% in 2022, its largest moves.
• CorMedix's Shares Outstanding (Weighted Average) stood at $37.7 million in 2021, then rose by 6.92% to $40.3 million in 2022, then gained by 26.39% to $50.9 million in 2023, then sank by 99.88% to $58872.0 in 2024, then climbed by 22.36% to $72034.0 in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $72034.0 (Q4 2025), $69.7 million (Q3 2025), and $66.6 million (Q2 2025), per Business Quant data.